Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking approach to diabetes management. These innovative drugs operate by mimicking the physiological actions of GLP-1, a hormone released by https://bookmarksea.com/story20750060/reta-glucagon-like-peptide-1-receptor-agonists